While Merlin restricts tumor invasive abilities (Figure 5C; Supplementary Data 2C), the S37A β-catenin mutant restored invasive capabilities of SUM159 breast cancer cells stably-expressing Merlin (Figure 5C) and enabled these breast cancer cells to escape contact-inhibition of growth (Figure 5D). The gene discussed is NF2; the disease is breast cancer.